After a tumultuous year, a popular virtual care platform is trying its hand in a competitive blood testing market.

Hims & Hers Health recently reported third-quarter results with revenues of US$598.98 million, net income of US$15.77 million, and impairment charges of US$531,000, while also narrowing full-year 2025 ...

Although Hims & Hers Health has tanked in the past month, the quantitative profile suggests a contrarian trade is brewing for ...

Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories.

The parents of Luke Tyler, a WSU freshman found dead in his dorm, allege his death was a consequence of Hims' reckless ...

Hims & Hers delivered yet another strong quarter of revenue growth in Q3, with sales climbing 49% year over year to $599 ...

This week, the parents of Luke Tyler, the Washington State University (WSU) freshman who was found dead in his dorm room on January 22, 2023, filed a wrongful death lawsuit in the King County Superior ...

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of Labs, a new ...

Hims and Hers Health beat Wall Street estimates for third-quarter revenue on Monday, as the telehealth company added ...

The telehealth platform will allow customers to access testing at more than 1,000 Quest Diagnostics locations nationwide. After testing, users will receive results and consult with providers on the ...

Mixed options sentiment in Hims and Hers Health (HIMS), with shares down $2.48 near $36.53. Options volume running well above average with 190k ...

Discover why Hims & Hers Health (HIMS) remains a strong long-term buy after robust Q3 growth, new offerings, and expansion ...